Your browser doesn't support javascript.
loading
Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
Ip, Michael S; Domalpally, Amitha; Sun, Jennifer K; Ehrlich, Jason S.
Afiliación
  • Ip MS; Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin. Electronic address: msip@wisc.edu.
  • Domalpally A; Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
  • Sun JK; Joslin Diabetes Center, Harvard Department of Ophthalmology, Boston, Massachusetts.
  • Ehrlich JS; Genentech, Inc., South San Francisco, California.
Ophthalmology ; 122(2): 367-74, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25439595
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Retinopatía Diabética / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Retinopatía Diabética / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Año: 2015 Tipo del documento: Article